Rhodiola rosea-derived exosome-like nanovesicles inhibit vascular endothelial pyroptosis in the treatment of limb skeletal muscle ischemic injury through the TXNIP/NLNP3 pathway
Regenerative Biomaterials · 06.01.2025 · 12
DOI: 10.1093/rb/rbaf113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative Biomaterials, online erschienen am 31.10.2025. Verfasst von Dachang Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nankai University, Tianjin 300071, China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Tianjin Health Research, Tianjin Key Medical Discipline Construction.
Abstract (Originalsprache)
Skeletal muscle ischemia, resulting from impaired blood flow, is a prevalent clinical issue and a leading cause of amputation. Plant-derived exosome-like nanovesicles (ELNs) have emerged as promising candidates due to their diverse bioactive components with antioxidant, anti-inflammatory and regenerative properties. In this study, exosome-like nanovesicles (RhELNs) extracted from the root of Rhodiola rosea, a traditional Chinese medicine, were proved to have a good ability to promote the regeneration of vascular endothelial cells under hypoxia by EdU experiment and transwell experiment in vitro. After the treatment of mice with RhELNs injected into the tail vein, it was found that the inflammation level of the skeletal muscle of the mice was decreased, the degree of fibrosis was alleviated, the blood flow was restored, skeletal muscle atrophy and limb gangrene were improved. These results indicate that RhELNs can promote the recovery of ischemic skeletal muscle and angiogenesis. Furthermore, we identified a novel microRNA (novel-mirNA-115-5p) in RhELNs, which plays an important role in RhELNs. It protects vascular endothelial cells from mitochondrial damage by targeting TXNIP and it promotes vascular regeneration by reducing cellular pyroptosis under hypoxia conditions through inhibition of the TXNIP- NLRP3 pathway. These results suggest that RhELNs represent a promising new approach for treating lower limb skeletal muscle ischemic diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Nankai University, Tianjin 300071, China.
- Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Tianjin University Central Hospital; Department of Heart Center, The Third Central Hospital of Tianjin; Nankai University Affiliated Third Cen…
- Senior Department of Orthopedics, The Fourth Medical Centre, Chinese PLA Hospital, Beijing 100048, China.
- Tianjin ECMO Treatment and Training Base, Tianjin 300170, China.
- State Key Laboratory of Advanced Medical Materials and Devices, Institute of Biomedical Engineering, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300192, China.
- Department of Thoracic Surgery, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610000, China.
ORCID-Profile: Wenqing Gao
Förderung
- National Natural Science Foundation of China
- Tianjin Health Research
- Tianjin Key Medical Discipline Construction
- Beijing Natural Science Foundation
Zitieren
APA
Liu, D., Zhang, Z., Wang, Y., Liang, X., Chang, Y., Wang, C., Guo, Y., Zhang, S., Zhou, J., Zhang, M., Shen, H., Zhang, X., & Gao, W. (2025). Rhodiola rosea-derived exosome-like nanovesicles inhibit vascular endothelial pyroptosis in the treatment of limb skeletal muscle ischemic injury through the TXNIP/NLNP3 pathway. Regenerative Biomaterials, 12. https://doi.org/10.1093/rb/rbaf113
Vancouver
Liu D, Zhang Z, Wang Y, Liang X, Chang Y, Wang C, et al. Rhodiola rosea-derived exosome-like nanovesicles inhibit vascular endothelial pyroptosis in the treatment of limb skeletal muscle ischemic injury through the TXNIP/NLNP3 pathway. Regenerative Biomaterials. 2025;12. doi:10.1093/rb/rbaf113
BibTeX
@article{Liu2025,
author = {Liu, Dachang and Zhang, Zhibin and Wang, Yuchao and Liang, Xiaoyu and Chang, Yun and Wang, Changduo and Guo, Yaming and Zhang, Shijie and Zhou, Jianghui and Zhang, Meng and Shen, Hechen and Zhang, Xuesong and Gao, Wenqing},
title = {Rhodiola rosea-derived exosome-like nanovesicles inhibit vascular endothelial pyroptosis in the treatment of limb skeletal muscle ischemic injury through the TXNIP/NLNP3 pathway},
journal = {Regenerative Biomaterials},
year = {2025},
volume = {12},
doi = {10.1093/rb/rbaf113}
}
EUVIMED